Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Cancer Drug Resistance (Alhambra, Calif.)|September 17, 2021
Advances in preclinical evaluation of experimental antibody-drug conjugatesScott K Lyons, Dennis Plenker, Lloyd C TrotmanExpert Opinion on Drug Metabolism & Toxicology|June 27, 2019
Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancerRyan Sugarman, Rajvi Patel, Sandhya Sharma, et al.ACS Chemical Biology|June 25, 2014
Discovery of inter-domain stabilizers-a novel assay system for allosteric akt inhibitorsZhizhou Fang, Jeffrey R Simard, Dennis Plenker, et al.SLAS Discovery : Advancing Life Sciences R & D|March 20, 2022
Lead identification using 3D models of pancreatic cancerVirneliz Fernandez-Vega, Shurong Hou, Dennis Plenker, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 3, 2020
Single-Pass vs 2-Pass Endoscopic Ultrasound-Guided Fine-Needle Biopsy Sample Collection for Creation of Pancreatic Adenocarcinoma OrganoidsJoseph F Lacomb, Dennis Plenker, Hervé Tiriac, et al.Cancer Research|June 8, 2023
Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung CancerNina Müller, Carina Lorenz, Jenny Ostendorp, et al.Oncotarget|November 6, 2015
Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancerJakob Schöttle, Sampurna Chatterjee, Caroline Volz, et al.Cancer Research|February 18, 2022
Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic CharacteristicsSonam Bhatia, Melissa Kramer, Suzanne Russo, et al.Molecular Cancer Therapeutics|March 5, 2022
CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 HeterodimerizationLisa Werr, Dennis Plenker, Marcel A Dammert, et al.Nature Cancer|March 6, 2024
Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cellsTajinder Ubhi, Olga Zaslaver, Andrew T Quaile, et al.Pageof 3